Drug Shortage Report for SURVANTA
| Report ID | 206918 |
| Drug Identification Number | 02016109 |
| Brand name | SURVANTA |
| Common or Proper name | SURVANTA 8 mL |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | BERACTANT |
| Strength(s) | 25MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRATRACHEAL INTRATRACHEAL |
| Packaging size | 8 mL Vial |
| ATC code | R07AA |
| ATC description | OTHER RESPIRATORY SYSTEM PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-04-01 |
| Actual start date | |
| Estimated end date | 2024-06-28 |
| Actual end date | 2023-11-27 |
| Shortage status | Avoided shortage |
| Updated date | 2023-12-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-12-01 | French | Compare |
| v3 | 2023-12-01 | English | Compare |
| v2 | 2023-10-12 | French | Compare |
| v1 | 2023-10-12 | English | Compare |
Showing 1 to 4 of 4